Markus Kapp

1.5k total citations
51 papers, 1.0k citations indexed

About

Markus Kapp is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Markus Kapp has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 18 papers in Immunology and 17 papers in Oncology. Recurrent topics in Markus Kapp's work include Cytomegalovirus and herpesvirus research (17 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Immune Cell Function and Interaction (10 papers). Markus Kapp is often cited by papers focused on Cytomegalovirus and herpesvirus research (17 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Immune Cell Function and Interaction (10 papers). Markus Kapp collaborates with scholars based in Germany, Japan and United States. Markus Kapp's co-authors include Hermann Einsele, Shigeo Fuji, Götz Ulrich Grigoleit, Hermann Einsele, Leo Rasche, Stephan Mielke, Rolf Knippers, Dieter G. Müller, Bipin N. Savani and Sen Mui Tan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Markus Kapp

50 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Kapp Germany 20 315 306 269 251 237 51 1.0k
Cristina Díaz de Heredia Spain 23 325 1.0× 312 1.0× 223 0.8× 727 2.9× 298 1.3× 129 1.6k
Hidemi Toyoda Japan 18 157 0.5× 117 0.4× 264 1.0× 89 0.4× 325 1.4× 63 956
Zinaida Perić Croatia 19 467 1.5× 134 0.4× 417 1.6× 629 2.5× 172 0.7× 72 1.4k
David H. Dreyfus United States 20 429 1.4× 280 0.9× 374 1.4× 48 0.2× 171 0.7× 45 1.5k
Stephanie L. Williams United States 15 278 0.9× 204 0.7× 114 0.4× 298 1.2× 141 0.6× 21 817
R. Hehlmann Germany 16 326 1.0× 167 0.5× 169 0.6× 135 0.5× 247 1.0× 30 859
Alan L. Hiti United States 20 140 0.4× 349 1.1× 111 0.4× 866 3.5× 640 2.7× 28 2.2k
Alberto Gómez Colombia 15 134 0.4× 127 0.4× 130 0.5× 87 0.3× 172 0.7× 109 805
Sophie Iochmann France 21 214 0.7× 90 0.3× 136 0.5× 369 1.5× 493 2.1× 39 1.5k
Cheryl Hutchins Australia 15 87 0.3× 70 0.2× 100 0.4× 245 1.0× 393 1.7× 32 1.2k

Countries citing papers authored by Markus Kapp

Since Specialization
Citations

This map shows the geographic impact of Markus Kapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Kapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Kapp more than expected).

Fields of papers citing papers by Markus Kapp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Kapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Kapp. The network helps show where Markus Kapp may publish in the future.

Co-authorship network of co-authors of Markus Kapp

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Kapp. A scholar is included among the top collaborators of Markus Kapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Kapp. Markus Kapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuji, Shigeo, Alicia Rovó, Michelle L. Griffith, et al.. (2016). How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT. Bone Marrow Transplantation. 51(8). 1041–1049. 21 indexed citations
2.
Fuji, Shigeo, Jürgen Löffler, Hermann Einsele, & Markus Kapp. (2016). Immunotherapy for opportunistic infections: Current status and future perspectives. Virulence. 7(8). 939–949. 9 indexed citations
3.
Tomuleasa, Ciprian, Shigeo Fuji, Andrei Cucuianu, et al.. (2015). MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation. Annals of Hematology. 94(7). 1081–1092. 16 indexed citations
4.
Kapp, Markus, Stephan Mielke, Jürgen Loeffler, et al.. (2015). Control of relapsed or refractory acute myeloid leukemia by clofarabine in preparation for allogeneic stem cell transplant. Leukemia & lymphoma. 56(12). 3365–3369. 1 indexed citations
5.
Einsele, Hermann, Jürgen Löffler, Markus Kapp, et al.. (2015). Immunotherapy for viral and fungal infections. Bone Marrow Transplantation. 50(S2). S51–S54. 11 indexed citations
6.
Mielke, Stephan, Mathias Lutz, Markus Kapp, et al.. (2014). Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis. Bone Marrow Transplantation. 49(11). 1412–1418. 13 indexed citations
7.
Kunzmann, Volker, Ken Herrmann, Christina Bluemel, et al.. (2014). Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer. Case Reports in Oncology. 7(3). 648–655. 13 indexed citations
8.
Fuji, Shigeo, Markus Kapp, & Hermann Einsele. (2013). Alloreactivity of Virus-Specific T Cells: Possible Implication of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effects. Frontiers in Immunology. 4. 330–330. 12 indexed citations
9.
Kapp, Markus, Marc Schargus, Jan Springer, et al.. (2011). Endophthalmitis as primary clinical manifestation of fatal fusariosis in an allogeneic stem cell recipient. Transplant Infectious Disease. 13(4). 374–379. 13 indexed citations
10.
Fuji, Shigeo, Markus Kapp, Götz Ulrich Grigoleit, & Hermann Einsele. (2011). Adoptive immunotherapy with virus-specific T cells. Best Practice & Research Clinical Haematology. 24(3). 413–419. 22 indexed citations
11.
Müller, Nicole, Markus Kapp, Götz Ulrich Grigoleit, et al.. (2011). SMAC Mimetic BV6 Induces Cell Death in Monocytes and Maturation of Monocyte-Derived Dendritic Cells. PLoS ONE. 6(6). e21556–e21556. 44 indexed citations
12.
Grigoleit, Götz Ulrich, et al.. (2009). Indirect Effects of Cytomegalovirus Infection. European Oncology & Haematology. 3(1). 41–41. 7 indexed citations
13.
Kapp, Markus, Stefan Stevanović, Sen Mui Tan, et al.. (2009). CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT. Bone Marrow Transplantation. 43(5). 399–410. 42 indexed citations
14.
15.
Kapp, Markus, Sen Mui Tan, Hermann Einsele, & Götz Ulrich Grigoleit. (2007). Adoptive immunotherapy of HCMV infection. Cytotherapy. 9(8). 699–711. 20 indexed citations
16.
Einsele, Hermann, Markus Kapp, & Götz Ulrich Grigoleit. (2007). CMV-specific T cell therapy. Blood Cells Molecules and Diseases. 40(1). 71–75. 56 indexed citations
17.
Grigoleit, Ulrich, Markus Kapp, & Hermann Einsele. (2006). Adoptive T lymphocyte therapy to fight cytomegalovirus infection in immunodeficient hosts. Drug Discovery Today Therapeutic Strategies. 3(1). 63–68. 1 indexed citations
18.
Müller, Dieter G., Markus Kapp, & Rolf Knippers. (1998). Viruses in Marine Brown Algae. Advances in virus research. 50. 49–67. 60 indexed citations
19.
Kapp, Markus, Rolf Knippers, & Dieter G. Müller. (1997). New members of a group of DNA viruses infecting brown algae. Phycological Research. 45(2). 85–90. 17 indexed citations
20.
Sengco, Mario R., et al.. (1996). Detection of virus DNA inEctocarpus siliculosusandE. fasciculatus(Phaeophyceae) from various geographic areas. European Journal of Phycology. 31(1). 73–78. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026